Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,143 public trials 560 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

Qidong Hepatitis B Intervention Study

NCT00222664

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +17 more
Locations
  • Qidong Liver Cancer Institute Qidong, Jiangsu, China
  • Cancer Institute, Chinese Academy of Medical Sciences Beijing, China
  • Clinical Trial Service Unit and Epidemiological Studies Unit Oxford, United Kingdom
View Trial Details
Terminated

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

NCT05908786

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • University of Southern California (USC) Los Angeles, California, United States
  • University of California Los Angeles (UCLA) - Cancer Care - Santa Monica Santa Monica, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Columbia University Medical Center New York, United States
View all 14 locations
View Trial Details
Terminated

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

NCT04246177

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Arizona Oncology Associates PC- HOPE ( Site 0770) Tucson, Arizona, United States
  • Scripps Clinic Torrey Pines ( Site 0714) La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center ( Site 0717) Los Angeles, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0720) Los Angeles, California, United States
View all 205 locations
View Trial Details
Terminated

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

NCT04601428

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • National Cheng Kung University Hospital (NCKUH) Tainan, North Dist., Taiwan
  • Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC) Taipei, Pei-Tou Dist., Taiwan
  • National Taiwan University Hospital (NTUH) Taipei, Zhongzheng Dist., Taiwan
  • KFSYSCC Taipei, Taiwan
View Trial Details
Terminated

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

NCT05435014

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Tungs' Taichung Metroharbor Hospital Taichung, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Terminated

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

NCT05199285

Conditions
Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +19 more
Locations
  • University of Alabama- Birmingham Birmingham, Alabama, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions